These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 6821504)

  • 1. [Studies of the effect of antituberculosis agents against tubercle bacilli of the chronic tuberculosis in mice].
    Mabuchi H
    Bull Chest Dis Res Inst Kyoto Univ; 1980 Mar; 13(1-2):25-31. PubMed ID: 6821504
    [No Abstract]   [Full Text] [Related]  

  • 2. [Studies on tubercle bacilli in the resected specimens of pulmonary tuberculosis].
    Kameda K; Iwai K; Iwasaki T; Oka S; Takahashi T
    Kekkaku; 1970 Apr; 45(4):143-51. PubMed ID: 4986909
    [No Abstract]   [Full Text] [Related]  

  • 3. [Study of tubercle bacilli from persistently sputum-positive patients treated with antituberculosis drugs for long duration in 3 Shanghai districts].
    Zhonghua Jie He He Hu Xi Xi Ji Bing Za Zhi; 1983 Aug; 6(4):222-4. PubMed ID: 6418491
    [No Abstract]   [Full Text] [Related]  

  • 4. [Changes in the number and virulence of tubercle bacilli isolated form pulmonary tuberculosis during short course chemotherapy].
    Chen SH
    Zhonghua Jie He He Hu Xi Za Zhi; 1990 Oct; 13(5):286-8, 318. PubMed ID: 2128212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Dynamics of the release of bacilli and the closing of caverns in newly identified tuberculosis patients undergoing different chemotherapeutic regimens].
    Muratov VV; Pashkov IuN; Pospelov VV
    Probl Tuberk; 1981 Dec; (12):30-4. PubMed ID: 6801646
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effectiveness of different chemotherapy regimens with pulmonary tuberculosis patients based on the data from a comprehensive bacteriological study].
    Muratov VV; Pashkov IuN; Chukanov VI
    Probl Tuberk; 1983 May; (5):34-8. PubMed ID: 6408636
    [No Abstract]   [Full Text] [Related]  

  • 7. [Formation of a filterable form of the causative agent of tuberculosis in the chemotherapy process (an experimental study)].
    Khomenko AK; Golyshevskaia VI; Korolev MB; Drozdov SG
    Probl Tuberk; 1982 Mar; (3):50-4. PubMed ID: 6806805
    [No Abstract]   [Full Text] [Related]  

  • 8. [Outlook for using a short course of chemotherapy in tuberculosis].
    Anastasatu C; Corlan E
    Probl Tuberk; 1987; (10):31-4. PubMed ID: 3122200
    [No Abstract]   [Full Text] [Related]  

  • 9. [Th 13-14 and PZA and CS in the treatment of chronic cavitary tuberculosis with bacterial resistance to classic antibacterial drugs].
    Zunić D
    Tuberkuloza; 1966; 18(5):429-40. PubMed ID: 16296047
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical significance of Mycobacterium tuberculosis polydrug resistance in chronic destructive forms of pulmonary tuberculosis].
    Bialik IB; Klimenko MT
    Probl Tuberk; 1980 Oct; (10):68-70. PubMed ID: 6776517
    [No Abstract]   [Full Text] [Related]  

  • 11. Two excellent management tools for national tuberculosis programmes: history of prior treatment and sputum status at two months.
    Trébucq A; Rieder HL
    Int J Tuberc Lung Dis; 1998 Mar; 2(3):184-6. PubMed ID: 9526189
    [No Abstract]   [Full Text] [Related]  

  • 12. [Case of pulmonary multi-drug resistant tuberculosis with left destroyed lung, treated with pneumonectomy].
    Koyama K; Kawakami K; Harada Y; Yamaryo T; Kimura Y
    Kekkaku; 2007 Jul; 82(7):577-81. PubMed ID: 17695788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Dynamics of isolation of mycobacterium tuberculosis during 2-stage standard chemotherapy].
    Khomenko AG; Vasil'eva IA
    Probl Tuberk; 1996; (6):52-4. PubMed ID: 9019772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Bacterial excretion and the bacteriostatic activity of the blood in the chemotherapy of middle-aged and elderly tuberculosis patients].
    Ginzburg TS; Iakimets VP
    Probl Tuberk; 1983 May; (5):57-61. PubMed ID: 6408638
    [No Abstract]   [Full Text] [Related]  

  • 15. [Improved methods of isolating altered forms of Mycobacterium tuberculosis in patients with stable destructive changes in lung tissue].
    Golyshevskaia VI; Akhunov ShB; Bibergal' EA
    Probl Tuberk; 1987; (10):61-5. PubMed ID: 3122201
    [No Abstract]   [Full Text] [Related]  

  • 16. [New cases of pulmonary tuberculosis treatment within DOTS strategy].
    Zhangireev AA; Ismailov ShSh; Berikova EM
    Probl Tuberk; 2000; (3):23-5. PubMed ID: 10900979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pathogenetic drugs in the treatment of destructive pulmonary tuberculosis in adolescents and adults].
    Buĭko RG; Maksimova NM
    Probl Tuberk; 1984 Jan; (1):45-9. PubMed ID: 6422459
    [No Abstract]   [Full Text] [Related]  

  • 18. [Intermittent chemotherapy of patients with fibrous-cavernous pulmonary tuberculosis in a hospital].
    Kovalenko NN; Ginzburg TS; Kunichkina SA
    Probl Tuberk; 1987; (11):35-7. PubMed ID: 3125538
    [No Abstract]   [Full Text] [Related]  

  • 19. Case 5: presentation. Pulmonary tuberculosis.
    Starke JR
    Paediatr Respir Rev; 2001 Jun; 2(2):196, 199. PubMed ID: 12531074
    [No Abstract]   [Full Text] [Related]  

  • 20. [Relationship between the susceptibility testing of Mycobacterium avium complex strains and the clinical efficacy of antituberculosis drugs--an evidence suggesting that antituberculosis drugs are effective in the treatment of M. avium complex pulmonary infection].
    Tsukamura M; Ichiyama S; Miyachi T
    Kekkaku; 1988 Apr; 63(4):227-31. PubMed ID: 3404801
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.